Company Active LTD

Company profile

Smithkline Beecham Limited

UK company 02337959, incorporated on 24 January 1989.

Home | GSK

At GSK, we unite science, technology and talent to get ahead of disease together

Company number
02337959
Incorporated
24 Jan 1989
Companies House status
Active

Company identity

Founded / incorporated
24 January 1989

Company number 02337959

Verify at Companies House
Legal name
SMITHKLINE BEECHAM LIMITED
Company type
Private Limited Company
Region
London
Registered address
79 NEW OXFORD STREET
LONDON
UNITED KINGDOM
WC1A 1DG
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

13 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

29 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

24 Jan
1989

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2015
Funded years
2015, 2016
Age at first award
26 years

Projects

2016 Collaborative R&D Lead participant

Enhancing the yield of industrial Actinomycete fermentations

1 Aug 2016 to 31 Jul 2019

Awarded
£398,000
Total cost £796,000

Clavulanic acid (CA) is a beta-lactamase inhibitor able to potentiate the antibacterial activity of penicillins against otherwise resistant bacteria. It is the product of complex biological factories found naturally in Streptomyces clavuligerus, and is currently made industrially via fermentation using a strain that has been through successive rounds of n...

2015 Collaborative R&D Lead participant

Developing a Quorum Sensing system into an efficient and economical way to control industrial production of high value products

1 Jul 2015 to 30 Jun 2018

Awarded
£543,750
Total cost £1,087,500

Natural or engineered biosynthesis can replace chemical synthesis with more environmentally friendly, sustainable bio-manufacturing processes to generate small molecule products such as pharmaceuticals. Although expression systems for recombinant proteins have been developed for laboratory scale and for commercial expression of very high value products su...

Product types

Collaborative R&D